What is LBRX's enterprise value?

LBRX (LBRX) reported enterprise value of $389.92M in Q1 2026.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

LBRX LBRX Enterprise value

Enterprise value at other companies

Bristol-Myers SquibbBMY

$158.92B-2.6%

AlkermesALKS

$7.12B+41.2%

MapLight Therapeutics, Inc. MPLT

$812.61M—

Alto NeuroscienceANRO

$474.75M+712%

Zevra Therapeutics, Inc.ZVRA

$452.74M+5.3%

Opko HealthOPK

$918.12M-21.5%

Other financials

Income statement

See full

Net income-$19.1M-259%

EPS (diluted)-$0.67+95.5%

Balance sheet

See full

Cash & equivalents$320.7M—

Total debt$3.5M—

Total equity$378.7M+481%

Total assets$393.5M—

Cash flow

See full

Operating cash flow-$23.3M-187%

CapEx$32.0K+52.4%

Free cash flow-$23.3M-186%

Valuation

See full

Market cap$874.06M+159%

Returns & leverage

See full

Return on equity-27.9%—

Debt / equity0×—

Current ratio35.7×—

Where this comes from

Calculated from LBRX’s reported figures.

$707.1Mmarket cap+$3.5Mtotal debt−$320.7Mcash and equivalents=$389.92M

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LBRX's enterprise value?: LBRX (LBRX) reported enterprise value of $389.92M in Q1 2026.
What does enterprise value mean?: Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.